Enantioselective Enzyme-Catalyzed Aziridination Enabled by Active-Site Evolution of a Cytochrome P450
Creators
Abstract
One of the greatest challenges in protein design is creating new enzymes, something evolution does all the time, starting from existing ones. Borrowing from nature's evolutionary strategy, we have engineered a bacterial cytochrome P450 to catalyze highly enantioselective intermolecular aziridination, a synthetically useful reaction that has no natural biological counterpart. The new enzyme is fully genetically encoded, functions in vitro or in whole cells, and can be optimized rapidly to exhibit high enantioselectivity (up to 99% ee) and productivity (up to 1,000 catalytic turnovers) for intermolecular aziridination, demonstrated here with tosyl azide and substituted styrenes. This new aziridination activity highlights the remarkable ability of a natural enzyme to adapt and take on new functions. Once discovered in an evolvable enzyme, this non-natural activity was improved and its selectivity tuned through an evolutionary process of accumulating beneficial mutations.
Additional Information
© 2015 American Chemical Society. This is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes. Received: February 23, 2015. Publication Date (Web): April 22, 2015. We thank Dr. S. Virgil and the 3CS Catalysis Center at Caltech for assistance with HPLC, chiral HPLC, and LC−MS analysis. We thank Yufan Liang for assistance with chiral HPLC, and Hans Renata, Christopher Prier, and Sheel Dodani for helpful discussions. This work was supported by the Department of the Navy, Office of Naval Research (Grant N00014-11-0205), and the Jacobs Institute for Molecular Engineering for Medicine at Caltech. C.C.F and R.K.Z. are supported by NSF graduate research fellowships. T.K.H and J.A.M. are supported by Ruth L. Kirschstein National Research Service Awards (F32GM108143) (F32GM101792).Attached Files
Published - acscentsci_2E5b00056.pdf
Supplemental Material - oc5b00056_si_001.pdf
Files
acscentsci_2E5b00056.pdf
Additional details
Identifiers
- PMCID
- PMC4571169
- Eprint ID
- 57182
- Resolver ID
- CaltechAUTHORS:20150504-091714076
Funding
- Office of Naval Research (ONR)
- N00014-11-0205
- Jacobs Institute for Molecular Engineering for Medicine
- NSF Graduate Research Fellowship
- NIH Predoctoral Fellowship
- F32GM108143
- NIH Predoctoral Fellowship
- F32GM101792
Dates
- Created
-
2015-05-04Created from EPrint's datestamp field
- Updated
-
2022-06-06Created from EPrint's last_modified field
Caltech Custom Metadata
- Caltech groups
- Jacobs Institute for Molecular Engineering for Medicine